Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Hardman Talks Video | Surface Transforms (SCE): Placing

14 May 2024 13:49

Hardman & Co Research Hardman Talks Video | Surface Transforms (SCE): Placing 14-May-2024 / 13:49 GMT/BST The issuer is solely responsible for the content of this announcement.


Hardman Talks Video | Surface Transforms (SCE)

Surface Transforms placing

On Thursday 9 May 2024, the management of Surface Transforms joined us on Hardman Talks to talk about the plans to raise money by a placing and the intended use of the proceeds. On the call were David Bundred, Chairman, Kevin Johnson, CEO, Isabelle Maddock, CFO, and Stephen Easton, who recently joined as Chief Operations Officer.

Following the formal presentation there was an extensive Q&A session covering a wide range of issues of interest to investors. In particular, this was the first opportunity for retail investors to hear about the work of the new COO in driving up efficiency. An explanation was given as to why the placing was necessary and how the proceeds will be deployed.

Watch the recording: https://youtu.be/n7ICmNGjGhg

Read more about the event here: https://hardmanandco.com/hardman-talks-surface-transforms-placing/

To be first in the know about Hardman & Co’s latest digital events, subscribe to the mailing list here.

The Hardman Talks series is designed to share the latest sector insights and company investment cases from our corporate clients and our expert team of analysts. Click here to subscribe to the Hardman Talks channel on YouTube.

Hardman & Co | 9 Bonhill Street | London | EC2A 4DJ | www.hardmanandco.com

 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors’ understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies’ profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1902885 14-May-2024 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
27th Feb 20187:00 amRNSHalf-year Report
4th Jan 20187:00 amRNSGrant of Options
2nd Jan 201812:05 pmRNSAppointment of new Financial Director
28th Nov 20172:18 pmRNSResult of AGM
20th Nov 20177:00 amRNSTrading and Operations Update
20th Sep 201712:07 pmRNSHolding(s) in Company
20th Sep 20179:34 amRNSGrant of Options
19th Sep 20177:00 amRNSPreliminary Results and Notice of AGM
9th Aug 20173:47 pmRNSResult of Open Offer Excess
27th Jul 20174:29 pmRNSHolding(s) in Company
26th Jul 201711:21 amRNSOpen Offer Excess
25th Jul 201711:51 amRNSResult of General Meeting
25th Jul 201711:13 amRNSResult of Open Offer
6th Jul 20173:00 pmRNSDirector/PDMR Shareholding
6th Jul 201712:09 pmRNSResult of Placing
6th Jul 201711:45 amRNSResult of Placing
6th Jul 20177:00 amRNSProposed Placing and Open Offer
20th Jun 20177:01 amRNSInvestors Open Day
20th Jun 20177:00 amRNSOperations, Customer and Pre Close Trading Update
18th Apr 20174:56 pmRNSExercise of Options
16th Mar 20178:20 amRNSExercise of Options
13th Feb 20177:00 amRNSHalf Yearly Results
2nd Feb 20177:00 amRNSTrading Update
6th Jan 20173:49 pmRNSChange of Registered Office
8th Dec 20167:00 amRNSTrading Update
29th Nov 20161:14 pmRNSResult of AGM
18th Oct 20164:14 pmRNSHolding(s) in Company
10th Oct 20167:00 amRNSPreliminary Results and Trading Statement
3rd Oct 20167:00 amRNSExercise of Options
5th Sep 20167:00 amRNSNotice of Results
2nd Aug 201610:42 amRNSHolding(s) in Company
11th Jul 20167:00 amRNSPre-Production Technology Development Agreement
15th Jun 20167:00 amRNSTrading, Premises and Operating Update
14th Apr 20165:18 pmRNSDirector Dealing
14th Apr 20162:33 pmRNSDirector Dealing & Director Interests in Company
14th Apr 20167:00 amRNSResult of Open Offer and Total Voting Rights
11th Apr 20167:00 amRNSDirector Dealing
6th Apr 201612:18 pmRNSHolding(s) in Company
4th Apr 20162:01 pmRNSResult of General Meeting
29th Mar 20167:00 amRNSDirector Dealing
18th Mar 20167:00 amRNSPlacing, Open Offer & Notice of General Meeting
18th Feb 20167:00 amRNSGrant Income of £600,000 and New Factory
3rd Feb 20167:00 amRNSHalf Yearly Results
7th Dec 20157:00 amRNSTrading Update
24th Nov 20154:00 pmRNSResult of AGM
12th Nov 201512:50 pmRNSReplacement: Exercise of Options
12th Nov 20157:00 amRNSExercise of Options
20th Oct 20158:51 amRNSHolding(s) in Company
8th Oct 201510:36 amRNSHolding(s) in Company
2nd Oct 201512:00 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.